Angiotech Pharmaceuticals Closes Acquisition of American Medical Instruments Holdings, Inc.
Angiotech Pharmaceuticals announced that it has closed the previously announced acquisition of American Medical Instruments Holdings, Inc. (AMI), a leading independent manufacturer of specialty, single-use medical devices, for approximately US $785 million in cash subject to post-closing adjustments. The transaction provides Angiotech with global manufacturing, marketing, and sales capabilities and enhances the Company's ability to capitalize on its current product pipeline in a wide range of specialty therapeutic areas. According to Angiotech, the acquisition of AMI also significantly diversifies Angiotech's revenue base.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.